$1.90 +0.08 (4.40%) Orexigen Therapeutics Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 1.90
Trade Time: Dec 02 04:00 PM Eastern Daylight Time
Change: +0.08 (4.40%)
Prev Close: 1.82
Open: 1.84
Bid: 1.89
Ask: 1.90
  1. No results found.
  1. Seth Klarman's Largest New Buys and Adds

    GuruFocus | Feb. 15, 2016 | 16:25PM EST
  2. Benzinga's Top Initiations

    Benzinga | Dec. 11, 2015 | 09:58AM EST
  3. Zafgen Plunges On Death In Obesity-Drug Trial

    IBD | Dec. 2, 2015 | 15:20PM EST
  4. Value Investing in BioPharma

    GuruFocus | Nov. 18, 2015 | 13:14PM EST
  5. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 16, 2015 | 07:13AM EST
  6. Seth Klarman Buys Pharmaceutical Company's Shares to Fund International Drug Launch

    GuruFocus | Oct. 12, 2015 | 16:36PM EST
  7. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 12, 2015 | 07:15AM EST
  8. Mid-Morning Market Update: Markets Mixed; FedEx Earnings Miss Estimates

    Benzinga | Sep. 16, 2015 | 09:25AM EST
  9. Mid-Morning Market Update: Markets Mostly Flat; Krispy Kreme Misses Q2 Estimates

    Benzinga | Sep. 10, 2015 | 09:14AM EST
  10. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 6, 2015 | 07:12AM EST
  11. Orexigen Announces Korean Distributorship Agreement with Kwang Dong Pharmaceutical Company

    Benzinga | Aug. 6, 2015 | 05:59AM EST
  12. Actavis faces suit over diet pill

    IBD | Jun. 5, 2015 | 17:47PM EST
  13. Tuesday's After-Hours Movers: Vertex Pharmaceuticals, Orexigen Therapeutics And More

    Benzinga | May. 12, 2015 | 20:22PM EST
  14. Report: Orexigen Therapeutics Jumped Gun On Contrave Heart Study

    Benzinga | Mar. 3, 2015 | 21:07PM EST
  15. Contrave may help heart

    IBD | Mar. 3, 2015 | 18:29PM EST
Trading Center